Drug survival of secukinumab for moderate-to-severe plaque psoriasis: reply from authors

A Egeberg, L Skov

Original languageEnglish
JournalBritish Journal of Dermatology
Volume179
Issue number1
Pages (from-to)222-223
Number of pages2
ISSN0007-0963
DOIs
Publication statusPublished - Jul 2018

Keywords

  • Antibodies, Monoclonal
  • Biological Factors
  • Biosimilar Pharmaceuticals
  • Humans
  • Psoriasis

Cite this